Lv2
115 积分 2020-08-02 加入
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
4个月前
已完结
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
4个月前
已完结
Classification histologique et moléculaire des cancers de l’endomètre et leurs implications dans la thérapeutique
1年前
已完结
皖公网安备34019202002308
